These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6372264)
41. Comparative theobromine metabolism in five mammalian species. Miller GE; Radulovic LL; DeWit RH; Brabec MJ; Tarka SM; Cornish HH Drug Metab Dispos; 1984; 12(2):154-60. PubMed ID: 6144479 [TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of amezinium in rat and dog. Traut M; Brode E; Neumann B; Kummer H Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974 [TBL] [Abstract][Full Text] [Related]
43. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys. Whitaker NG; Lindstrom TD Drug Metab Dispos; 1987; 15(1):107-13. PubMed ID: 2881745 [TBL] [Abstract][Full Text] [Related]
44. Distribution of captopril to foetuses and milk of rats. Ita CE; Singhvi SM; Heald AF; Migdalof BH Xenobiotica; 1982 Oct; 12(10):627-32. PubMed ID: 6760566 [TBL] [Abstract][Full Text] [Related]
46. Disposition of remoxipride in different species. Species differences in metabolism. Widman M; Nilsson LB; Bryske B; Lundström J Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [TBL] [Abstract][Full Text] [Related]
47. Combined gas chromatographic-mass spectrometric procedure for the measurement of captopril and sulfur-conjugated metabolites of captopril in plasma and urine. Drummer OH; Jarrott B; Louis WJ J Chromatogr; 1984 Jan; 305(1):83-93. PubMed ID: 6368577 [TBL] [Abstract][Full Text] [Related]
48. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences. Lan SJ; El-Hawey AM; Dean AV; Schreiber EC Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816 [TBL] [Abstract][Full Text] [Related]
49. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
50. Metabolism and excretion of the novel bioreductive prodrug PR-104 in mice, rats, dogs, and humans. Gu Y; Atwell GJ; Wilson WR Drug Metab Dispos; 2010 Mar; 38(3):498-508. PubMed ID: 20019245 [TBL] [Abstract][Full Text] [Related]
51. In vitro stability, plasma protein binding and blood cell partitioning of 14C-carboplatin. Gaver RC; George AM; Deeb G Cancer Chemother Pharmacol; 1987; 20(4):271-6. PubMed ID: 3319277 [TBL] [Abstract][Full Text] [Related]
52. Metabolites of 2-(3-trifluoromethylphenyl)tetrahydro-1,4-oxazine (CERM) 1841) in rats and dogs. Kucharczyk N; Yang JT; Valia KH; Stiefel FJ; Sofia RD Xenobiotica; 1979 Nov; 9(11):703-11. PubMed ID: 532219 [TBL] [Abstract][Full Text] [Related]
53. Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite. Paul H; Illing A; House ES Eur J Drug Metab Pharmacokinet; 1981; 6(4):303-12. PubMed ID: 7333331 [TBL] [Abstract][Full Text] [Related]
54. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine. Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402 [TBL] [Abstract][Full Text] [Related]
56. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390 [TBL] [Abstract][Full Text] [Related]
57. Biotransformation of bromperidol in rat, dog, and man. Wong FA; Bateman CP; Shaw CJ; Patrick JE Drug Metab Dispos; 1983; 11(4):301-7. PubMed ID: 6137334 [TBL] [Abstract][Full Text] [Related]
58. Disposition of cefotaxime in rat, dog and man. Macdonald CM; Fromson JM; McDonald A; Dell D; Chamberlain J; Coombes JD Arzneimittelforschung; 1984; 34(12):1719-23. PubMed ID: 6099125 [TBL] [Abstract][Full Text] [Related]
59. Identification of ibopamine metabolites in rat and dog urine. Kuo GY; Hwang BY; Lynn RK Drug Metab Dispos; 1988; 16(6):793-8. PubMed ID: 2907455 [TBL] [Abstract][Full Text] [Related]
60. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs. Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]